Global Recombinant Human Erythropoietin Injection Supply, Demand and Key Producers, 2023-2029
Page: 112
Published Date: 29 Jul 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Recombinant Human Erythropoietin Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need.
Recombinant human erythropoietin injection (CHO cells) is clinically used for anemia caused by renal insufficiency, including hemodialysis, peritoneal dialysis and non dialysis patients with chronic renal failure.
This report studies the global Recombinant Human Erythropoietin Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Human Erythropoietin Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Human Erythropoietin Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant Human Erythropoietin Injection total production and demand, 2018-2029, (K Units)
Global Recombinant Human Erythropoietin Injection total production value, 2018-2029, (USD Million)
Global Recombinant Human Erythropoietin Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human Erythropoietin Injection consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Human Erythropoietin Injection domestic production, consumption, key domestic manufacturers and share
Global Recombinant Human Erythropoietin Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Human Erythropoietin Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human Erythropoietin Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Recombinant Human Erythropoietin Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, LG Chem, Kexing Biopharm, 3SBio Group, Harbin Pharmaceutical Group Holding, Dong-E-E-Jiao, Humanwell Healthcare, Ncpc Genetech Biotechnology and Shandong E-hua Biotech Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Human Erythropoietin Injection market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Recombinant Human Erythropoietin Injection Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Recombinant Human Erythropoietin Injection Market, Segmentation by Type
0.3ml Branch
0.6ml Branch
1ml Branch
Others
Global Recombinant Human Erythropoietin Injection Market, Segmentation by Application
Renal Failure Anemia
Non Renal Anemia
Companies Profiled:
Roche
LG Chem
Kexing Biopharm
3SBio Group
Harbin Pharmaceutical Group Holding
Dong-E-E-Jiao
Humanwell Healthcare
Ncpc Genetech Biotechnology
Shandong E-hua Biotech Pharmaceutical
Intas Pharmaceuticals
PeproTech
WELLONA PHARMA
SI HUAN SHENG WU
Shanxi Weiqidaguangming Pharmaceutical
Key Questions Answered
1. How big is the global Recombinant Human Erythropoietin Injection market?
2. What is the demand of the global Recombinant Human Erythropoietin Injection market?
3. What is the year over year growth of the global Recombinant Human Erythropoietin Injection market?
4. What is the production and production value of the global Recombinant Human Erythropoietin Injection market?
5. Who are the key producers in the global Recombinant Human Erythropoietin Injection market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Recombinant Human Erythropoietin Injection Introduction
1.2 World Recombinant Human Erythropoietin Injection Supply & Forecast
1.2.1 World Recombinant Human Erythropoietin Injection Production Value (2018 & 2022 & 2029)
1.2.2 World Recombinant Human Erythropoietin Injection Production (2018-2029)
1.2.3 World Recombinant Human Erythropoietin Injection Pricing Trends (2018-2029)
1.3 World Recombinant Human Erythropoietin Injection Production by Region (Based on Production Site)
1.3.1 World Recombinant Human Erythropoietin Injection Production Value by Region (2018-2029)
1.3.2 World Recombinant Human Erythropoietin Injection Production by Region (2018-2029)
1.3.3 World Recombinant Human Erythropoietin Injection Average Price by Region (2018-2029)
1.3.4 North America Recombinant Human Erythropoietin Injection Production (2018-2029)
1.3.5 Europe Recombinant Human Erythropoietin Injection Production (2018-2029)
1.3.6 China Recombinant Human Erythropoietin Injection Production (2018-2029)
1.3.7 Japan Recombinant Human Erythropoietin Injection Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Human Erythropoietin Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Human Erythropoietin Injection Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2.1 World Recombinant Human Erythropoietin Injection Demand (2018-2029)
2.2 World Recombinant Human Erythropoietin Injection Consumption by Region
2.2.1 World Recombinant Human Erythropoietin Injection Consumption by Region (2018-2023)
2.2.2 World Recombinant Human Erythropoietin Injection Consumption Forecast by Region (2024-2029)
2.3 United States Recombinant Human Erythropoietin Injection Consumption (2018-2029)
2.4 China Recombinant Human Erythropoietin Injection Consumption (2018-2029)
2.5 Europe Recombinant Human Erythropoietin Injection Consumption (2018-2029)
2.6 Japan Recombinant Human Erythropoietin Injection Consumption (2018-2029)
2.7 South Korea Recombinant Human Erythropoietin Injection Consumption (2018-2029)
2.8 ASEAN Recombinant Human Erythropoietin Injection Consumption (2018-2029)
2.9 India Recombinant Human Erythropoietin Injection Consumption (2018-2029)
3.1 World Recombinant Human Erythropoietin Injection Production Value by Manufacturer (2018-2023)
3.2 World Recombinant Human Erythropoietin Injection Production by Manufacturer (2018-2023)
3.3 World Recombinant Human Erythropoietin Injection Average Price by Manufacturer (2018-2023)
3.4 Recombinant Human Erythropoietin Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Human Erythropoietin Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Human Erythropoietin Injection in 2022
3.5.3 Global Concentration Ratios (CR8) for Recombinant Human Erythropoietin Injection in 2022
3.6 Recombinant Human Erythropoietin Injection Market: Overall Company Footprint Analysis
3.6.1 Recombinant Human Erythropoietin Injection Market: Region Footprint
3.6.2 Recombinant Human Erythropoietin Injection Market: Company Product Type Footprint
3.6.3 Recombinant Human Erythropoietin Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Recombinant Human Erythropoietin Injection Production Value Comparison
4.1.1 United States VS China: Recombinant Human Erythropoietin Injection Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Recombinant Human Erythropoietin Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Recombinant Human Erythropoietin Injection Production Comparison
4.2.1 United States VS China: Recombinant Human Erythropoietin Injection Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Recombinant Human Erythropoietin Injection Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Recombinant Human Erythropoietin Injection Consumption Comparison
4.3.1 United States VS China: Recombinant Human Erythropoietin Injection Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Recombinant Human Erythropoietin Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Recombinant Human Erythropoietin Injection Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Recombinant Human Erythropoietin Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Human Erythropoietin Injection Production Value (2018-2023)
4.4.3 United States Based Manufacturers Recombinant Human Erythropoietin Injection Production (2018-2023)
4.5 China Based Recombinant Human Erythropoietin Injection Manufacturers and Market Share
4.5.1 China Based Recombinant Human Erythropoietin Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Human Erythropoietin Injection Production Value (2018-2023)
4.5.3 China Based Manufacturers Recombinant Human Erythropoietin Injection Production (2018-2023)
4.6 Rest of World Based Recombinant Human Erythropoietin Injection Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Recombinant Human Erythropoietin Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Human Erythropoietin Injection Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Recombinant Human Erythropoietin Injection Production (2018-2023)
5.1 World Recombinant Human Erythropoietin Injection Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 0.3ml Branch
5.2.2 0.6ml Branch
5.2.3 1ml Branch
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Recombinant Human Erythropoietin Injection Production by Type (2018-2029)
5.3.2 World Recombinant Human Erythropoietin Injection Production Value by Type (2018-2029)
5.3.3 World Recombinant Human Erythropoietin Injection Average Price by Type (2018-2029)
6.1 World Recombinant Human Erythropoietin Injection Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Renal Failure Anemia
6.2.2 Non Renal Anemia
6.3 Market Segment by Application
6.3.1 World Recombinant Human Erythropoietin Injection Production by Application (2018-2029)
6.3.2 World Recombinant Human Erythropoietin Injection Production Value by Application (2018-2029)
6.3.3 World Recombinant Human Erythropoietin Injection Average Price by Application (2018-2029)
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Recombinant Human Erythropoietin Injection Product and Services
7.1.4 Roche Recombinant Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 LG Chem
7.2.1 LG Chem Details
7.2.2 LG Chem Major Business
7.2.3 LG Chem Recombinant Human Erythropoietin Injection Product and Services
7.2.4 LG Chem Recombinant Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 LG Chem Recent Developments/Updates
7.2.6 LG Chem Competitive Strengths & Weaknesses
7.3 Kexing Biopharm
7.3.1 Kexing Biopharm Details
7.3.2 Kexing Biopharm Major Business
7.3.3 Kexing Biopharm Recombinant Human Erythropoietin Injection Product and Services
7.3.4 Kexing Biopharm Recombinant Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Kexing Biopharm Recent Developments/Updates
7.3.6 Kexing Biopharm Competitive Strengths & Weaknesses
7.4 3SBio Group
7.4.1 3SBio Group Details
7.4.2 3SBio Group Major Business
7.4.3 3SBio Group Recombinant Human Erythropoietin Injection Product and Services
7.4.4 3SBio Group Recombinant Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 3SBio Group Recent Developments/Updates
7.4.6 3SBio Group Competitive Strengths & Weaknesses
7.5 Harbin Pharmaceutical Group Holding
7.5.1 Harbin Pharmaceutical Group Holding Details
7.5.2 Harbin Pharmaceutical Group Holding Major Business
7.5.3 Harbin Pharmaceutical Group Holding Recombinant Human Erythropoietin Injection Product and Services
7.5.4 Harbin Pharmaceutical Group Holding Recombinant Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Harbin Pharmaceutical Group Holding Recent Developments/Updates
7.5.6 Harbin Pharmaceutical Group Holding Competitive Strengths & Weaknesses
7.6 Dong-E-E-Jiao
7.6.1 Dong-E-E-Jiao Details
7.6.2 Dong-E-E-Jiao Major Business
7.6.3 Dong-E-E-Jiao Recombinant Human Erythropoietin Injection Product and Services
7.6.4 Dong-E-E-Jiao Recombinant Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Dong-E-E-Jiao Recent Developments/Updates
7.6.6 Dong-E-E-Jiao Competitive Strengths & Weaknesses
7.7 Humanwell Healthcare
7.7.1 Humanwell Healthcare Details
7.7.2 Humanwell Healthcare Major Business
7.7.3 Humanwell Healthcare Recombinant Human Erythropoietin Injection Product and Services
7.7.4 Humanwell Healthcare Recombinant Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Humanwell Healthcare Recent Developments/Updates
7.7.6 Humanwell Healthcare Competitive Strengths & Weaknesses
7.8 Ncpc Genetech Biotechnology
7.8.1 Ncpc Genetech Biotechnology Details
7.8.2 Ncpc Genetech Biotechnology Major Business
7.8.3 Ncpc Genetech Biotechnology Recombinant Human Erythropoietin Injection Product and Services
7.8.4 Ncpc Genetech Biotechnology Recombinant Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Ncpc Genetech Biotechnology Recent Developments/Updates
7.8.6 Ncpc Genetech Biotechnology Competitive Strengths & Weaknesses
7.9 Shandong E-hua Biotech Pharmaceutical
7.9.1 Shandong E-hua Biotech Pharmaceutical Details
7.9.2 Shandong E-hua Biotech Pharmaceutical Major Business
7.9.3 Shandong E-hua Biotech Pharmaceutical Recombinant Human Erythropoietin Injection Product and Services
7.9.4 Shandong E-hua Biotech Pharmaceutical Recombinant Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Shandong E-hua Biotech Pharmaceutical Recent Developments/Updates
7.9.6 Shandong E-hua Biotech Pharmaceutical Competitive Strengths & Weaknesses
7.10 Intas Pharmaceuticals
7.10.1 Intas Pharmaceuticals Details
7.10.2 Intas Pharmaceuticals Major Business
7.10.3 Intas Pharmaceuticals Recombinant Human Erythropoietin Injection Product and Services
7.10.4 Intas Pharmaceuticals Recombinant Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Intas Pharmaceuticals Recent Developments/Updates
7.10.6 Intas Pharmaceuticals Competitive Strengths & Weaknesses
7.11 PeproTech
7.11.1 PeproTech Details
7.11.2 PeproTech Major Business
7.11.3 PeproTech Recombinant Human Erythropoietin Injection Product and Services
7.11.4 PeproTech Recombinant Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 PeproTech Recent Developments/Updates
7.11.6 PeproTech Competitive Strengths & Weaknesses
7.12 WELLONA PHARMA
7.12.1 WELLONA PHARMA Details
7.12.2 WELLONA PHARMA Major Business
7.12.3 WELLONA PHARMA Recombinant Human Erythropoietin Injection Product and Services
7.12.4 WELLONA PHARMA Recombinant Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 WELLONA PHARMA Recent Developments/Updates
7.12.6 WELLONA PHARMA Competitive Strengths & Weaknesses
7.13 SI HUAN SHENG WU
7.13.1 SI HUAN SHENG WU Details
7.13.2 SI HUAN SHENG WU Major Business
7.13.3 SI HUAN SHENG WU Recombinant Human Erythropoietin Injection Product and Services
7.13.4 SI HUAN SHENG WU Recombinant Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 SI HUAN SHENG WU Recent Developments/Updates
7.13.6 SI HUAN SHENG WU Competitive Strengths & Weaknesses
7.14 Shanxi Weiqidaguangming Pharmaceutical
7.14.1 Shanxi Weiqidaguangming Pharmaceutical Details
7.14.2 Shanxi Weiqidaguangming Pharmaceutical Major Business
7.14.3 Shanxi Weiqidaguangming Pharmaceutical Recombinant Human Erythropoietin Injection Product and Services
7.14.4 Shanxi Weiqidaguangming Pharmaceutical Recombinant Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Shanxi Weiqidaguangming Pharmaceutical Recent Developments/Updates
7.14.6 Shanxi Weiqidaguangming Pharmaceutical Competitive Strengths & Weaknesses
8.1 Recombinant Human Erythropoietin Injection Industry Chain
8.2 Recombinant Human Erythropoietin Injection Upstream Analysis
8.2.1 Recombinant Human Erythropoietin Injection Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Human Erythropoietin Injection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Human Erythropoietin Injection Production Mode
8.6 Recombinant Human Erythropoietin Injection Procurement Model
8.7 Recombinant Human Erythropoietin Injection Industry Sales Model and Sales Channels
8.7.1 Recombinant Human Erythropoietin Injection Sales Model
8.7.2 Recombinant Human Erythropoietin Injection Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Recombinant Human Erythropoietin Injection Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Recombinant Human Erythropoietin Injection Production Value by Region (2018-2023) & (USD Million)
Table 3. World Recombinant Human Erythropoietin Injection Production Value by Region (2024-2029) & (USD Million)
Table 4. World Recombinant Human Erythropoietin Injection Production Value Market Share by Region (2018-2023)
Table 5. World Recombinant Human Erythropoietin Injection Production Value Market Share by Region (2024-2029)
Table 6. World Recombinant Human Erythropoietin Injection Production by Region (2018-2023) & (K Units)
Table 7. World Recombinant Human Erythropoietin Injection Production by Region (2024-2029) & (K Units)
Table 8. World Recombinant Human Erythropoietin Injection Production Market Share by Region (2018-2023)
Table 9. World Recombinant Human Erythropoietin Injection Production Market Share by Region (2024-2029)
Table 10. World Recombinant Human Erythropoietin Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Recombinant Human Erythropoietin Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Recombinant Human Erythropoietin Injection Major Market Trends
Table 13. World Recombinant Human Erythropoietin Injection Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Recombinant Human Erythropoietin Injection Consumption by Region (2018-2023) & (K Units)
Table 15. World Recombinant Human Erythropoietin Injection Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Recombinant Human Erythropoietin Injection Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Human Erythropoietin Injection Producers in 2022
Table 18. World Recombinant Human Erythropoietin Injection Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Recombinant Human Erythropoietin Injection Producers in 2022
Table 20. World Recombinant Human Erythropoietin Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Recombinant Human Erythropoietin Injection Company Evaluation Quadrant
Table 22. World Recombinant Human Erythropoietin Injection Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Recombinant Human Erythropoietin Injection Production Site of Key Manufacturer
Table 24. Recombinant Human Erythropoietin Injection Market: Company Product Type Footprint
Table 25. Recombinant Human Erythropoietin Injection Market: Company Product Application Footprint
Table 26. Recombinant Human Erythropoietin Injection Competitive Factors
Table 27. Recombinant Human Erythropoietin Injection New Entrant and Capacity Expansion Plans
Table 28. Recombinant Human Erythropoietin Injection Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Human Erythropoietin Injection Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Recombinant Human Erythropoietin Injection Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Recombinant Human Erythropoietin Injection Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Recombinant Human Erythropoietin Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Human Erythropoietin Injection Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Human Erythropoietin Injection Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Recombinant Human Erythropoietin Injection Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Recombinant Human Erythropoietin Injection Production Market Share (2018-2023)
Table 37. China Based Recombinant Human Erythropoietin Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Human Erythropoietin Injection Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Recombinant Human Erythropoietin Injection Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Recombinant Human Erythropoietin Injection Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Recombinant Human Erythropoietin Injection Production Market Share (2018-2023)
Table 42. Rest of World Based Recombinant Human Erythropoietin Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Human Erythropoietin Injection Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Human Erythropoietin Injection Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Recombinant Human Erythropoietin Injection Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant Human Erythropoietin Injection Production Market Share (2018-2023)
Table 47. World Recombinant Human Erythropoietin Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Recombinant Human Erythropoietin Injection Production by Type (2018-2023) & (K Units)
Table 49. World Recombinant Human Erythropoietin Injection Production by Type (2024-2029) & (K Units)
Table 50. World Recombinant Human Erythropoietin Injection Production Value by Type (2018-2023) & (USD Million)
Table 51. World Recombinant Human Erythropoietin Injection Production Value by Type (2024-2029) & (USD Million)
Table 52. World Recombinant Human Erythropoietin Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Recombinant Human Erythropoietin Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Recombinant Human Erythropoietin Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Recombinant Human Erythropoietin Injection Production by Application (2018-2023) & (K Units)
Table 56. World Recombinant Human Erythropoietin Injection Production by Application (2024-2029) & (K Units)
Table 57. World Recombinant Human Erythropoietin Injection Production Value by Application (2018-2023) & (USD Million)
Table 58. World Recombinant Human Erythropoietin Injection Production Value by Application (2024-2029) & (USD Million)
Table 59. World Recombinant Human Erythropoietin Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Recombinant Human Erythropoietin Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche Recombinant Human Erythropoietin Injection Product and Services
Table 64. Roche Recombinant Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. LG Chem Basic Information, Manufacturing Base and Competitors
Table 68. LG Chem Major Business
Table 69. LG Chem Recombinant Human Erythropoietin Injection Product and Services
Table 70. LG Chem Recombinant Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. LG Chem Recent Developments/Updates
Table 72. LG Chem Competitive Strengths & Weaknesses
Table 73. Kexing Biopharm Basic Information, Manufacturing Base and Competitors
Table 74. Kexing Biopharm Major Business
Table 75. Kexing Biopharm Recombinant Human Erythropoietin Injection Product and Services
Table 76. Kexing Biopharm Recombinant Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Kexing Biopharm Recent Developments/Updates
Table 78. Kexing Biopharm Competitive Strengths & Weaknesses
Table 79. 3SBio Group Basic Information, Manufacturing Base and Competitors
Table 80. 3SBio Group Major Business
Table 81. 3SBio Group Recombinant Human Erythropoietin Injection Product and Services
Table 82. 3SBio Group Recombinant Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. 3SBio Group Recent Developments/Updates
Table 84. 3SBio Group Competitive Strengths & Weaknesses
Table 85. Harbin Pharmaceutical Group Holding Basic Information, Manufacturing Base and Competitors
Table 86. Harbin Pharmaceutical Group Holding Major Business
Table 87. Harbin Pharmaceutical Group Holding Recombinant Human Erythropoietin Injection Product and Services
Table 88. Harbin Pharmaceutical Group Holding Recombinant Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Harbin Pharmaceutical Group Holding Recent Developments/Updates
Table 90. Harbin Pharmaceutical Group Holding Competitive Strengths & Weaknesses
Table 91. Dong-E-E-Jiao Basic Information, Manufacturing Base and Competitors
Table 92. Dong-E-E-Jiao Major Business
Table 93. Dong-E-E-Jiao Recombinant Human Erythropoietin Injection Product and Services
Table 94. Dong-E-E-Jiao Recombinant Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Dong-E-E-Jiao Recent Developments/Updates
Table 96. Dong-E-E-Jiao Competitive Strengths & Weaknesses
Table 97. Humanwell Healthcare Basic Information, Manufacturing Base and Competitors
Table 98. Humanwell Healthcare Major Business
Table 99. Humanwell Healthcare Recombinant Human Erythropoietin Injection Product and Services
Table 100. Humanwell Healthcare Recombinant Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Humanwell Healthcare Recent Developments/Updates
Table 102. Humanwell Healthcare Competitive Strengths & Weaknesses
Table 103. Ncpc Genetech Biotechnology Basic Information, Manufacturing Base and Competitors
Table 104. Ncpc Genetech Biotechnology Major Business
Table 105. Ncpc Genetech Biotechnology Recombinant Human Erythropoietin Injection Product and Services
Table 106. Ncpc Genetech Biotechnology Recombinant Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Ncpc Genetech Biotechnology Recent Developments/Updates
Table 108. Ncpc Genetech Biotechnology Competitive Strengths & Weaknesses
Table 109. Shandong E-hua Biotech Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Shandong E-hua Biotech Pharmaceutical Major Business
Table 111. Shandong E-hua Biotech Pharmaceutical Recombinant Human Erythropoietin Injection Product and Services
Table 112. Shandong E-hua Biotech Pharmaceutical Recombinant Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Shandong E-hua Biotech Pharmaceutical Recent Developments/Updates
Table 114. Shandong E-hua Biotech Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Intas Pharmaceuticals Major Business
Table 117. Intas Pharmaceuticals Recombinant Human Erythropoietin Injection Product and Services
Table 118. Intas Pharmaceuticals Recombinant Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Intas Pharmaceuticals Recent Developments/Updates
Table 120. Intas Pharmaceuticals Competitive Strengths & Weaknesses
Table 121. PeproTech Basic Information, Manufacturing Base and Competitors
Table 122. PeproTech Major Business
Table 123. PeproTech Recombinant Human Erythropoietin Injection Product and Services
Table 124. PeproTech Recombinant Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. PeproTech Recent Developments/Updates
Table 126. PeproTech Competitive Strengths & Weaknesses
Table 127. WELLONA PHARMA Basic Information, Manufacturing Base and Competitors
Table 128. WELLONA PHARMA Major Business
Table 129. WELLONA PHARMA Recombinant Human Erythropoietin Injection Product and Services
Table 130. WELLONA PHARMA Recombinant Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. WELLONA PHARMA Recent Developments/Updates
Table 132. WELLONA PHARMA Competitive Strengths & Weaknesses
Table 133. SI HUAN SHENG WU Basic Information, Manufacturing Base and Competitors
Table 134. SI HUAN SHENG WU Major Business
Table 135. SI HUAN SHENG WU Recombinant Human Erythropoietin Injection Product and Services
Table 136. SI HUAN SHENG WU Recombinant Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. SI HUAN SHENG WU Recent Developments/Updates
Table 138. Shanxi Weiqidaguangming Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 139. Shanxi Weiqidaguangming Pharmaceutical Major Business
Table 140. Shanxi Weiqidaguangming Pharmaceutical Recombinant Human Erythropoietin Injection Product and Services
Table 141. Shanxi Weiqidaguangming Pharmaceutical Recombinant Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Recombinant Human Erythropoietin Injection Upstream (Raw Materials)
Table 143. Recombinant Human Erythropoietin Injection Typical Customers
Table 144. Recombinant Human Erythropoietin Injection Typical Distributors
List of Figure
Figure 1. Recombinant Human Erythropoietin Injection Picture
Figure 2. World Recombinant Human Erythropoietin Injection Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Recombinant Human Erythropoietin Injection Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Recombinant Human Erythropoietin Injection Production (2018-2029) & (K Units)
Figure 5. World Recombinant Human Erythropoietin Injection Average Price (2018-2029) & (US$/Unit)
Figure 6. World Recombinant Human Erythropoietin Injection Production Value Market Share by Region (2018-2029)
Figure 7. World Recombinant Human Erythropoietin Injection Production Market Share by Region (2018-2029)
Figure 8. North America Recombinant Human Erythropoietin Injection Production (2018-2029) & (K Units)
Figure 9. Europe Recombinant Human Erythropoietin Injection Production (2018-2029) & (K Units)
Figure 10. China Recombinant Human Erythropoietin Injection Production (2018-2029) & (K Units)
Figure 11. Japan Recombinant Human Erythropoietin Injection Production (2018-2029) & (K Units)
Figure 12. Recombinant Human Erythropoietin Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
Figure 15. World Recombinant Human Erythropoietin Injection Consumption Market Share by Region (2018-2029)
Figure 16. United States Recombinant Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
Figure 17. China Recombinant Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
Figure 18. Europe Recombinant Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
Figure 19. Japan Recombinant Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
Figure 20. South Korea Recombinant Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Recombinant Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
Figure 22. India Recombinant Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Recombinant Human Erythropoietin Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Human Erythropoietin Injection Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Human Erythropoietin Injection Markets in 2022
Figure 26. United States VS China: Recombinant Human Erythropoietin Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Recombinant Human Erythropoietin Injection Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Recombinant Human Erythropoietin Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Recombinant Human Erythropoietin Injection Production Market Share 2022
Figure 30. China Based Manufacturers Recombinant Human Erythropoietin Injection Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Recombinant Human Erythropoietin Injection Production Market Share 2022
Figure 32. World Recombinant Human Erythropoietin Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Recombinant Human Erythropoietin Injection Production Value Market Share by Type in 2022
Figure 34. 0.3ml Branch
Figure 35. 0.6ml Branch
Figure 36. 1ml Branch
Figure 37. Others
Figure 38. World Recombinant Human Erythropoietin Injection Production Market Share by Type (2018-2029)
Figure 39. World Recombinant Human Erythropoietin Injection Production Value Market Share by Type (2018-2029)
Figure 40. World Recombinant Human Erythropoietin Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Recombinant Human Erythropoietin Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Recombinant Human Erythropoietin Injection Production Value Market Share by Application in 2022
Figure 43. Renal Failure Anemia
Figure 44. Non Renal Anemia
Figure 45. World Recombinant Human Erythropoietin Injection Production Market Share by Application (2018-2029)
Figure 46. World Recombinant Human Erythropoietin Injection Production Value Market Share by Application (2018-2029)
Figure 47. World Recombinant Human Erythropoietin Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Recombinant Human Erythropoietin Injection Industry Chain
Figure 49. Recombinant Human Erythropoietin Injection Procurement Model
Figure 50. Recombinant Human Erythropoietin Injection Sales Model
Figure 51. Recombinant Human Erythropoietin Injection Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Roche LG Chem Kexing Biopharm 3SBio Group Harbin Pharmaceutical Group Holding Dong-E-E-Jiao Humanwell Healthcare Ncpc Genetech Biotechnology Shandong E-hua Biotech Pharmaceutical Intas Pharmaceuticals PeproTech WELLONA PHARMA SI HUAN SHENG WU Shanxi Weiqidaguangming Pharmaceutical
Related Reports
29 Jul 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
